With one of the largest life sciences practices in the U.S., Wilson Sonsini’s industry legacy dates to the formative years of biotech and medical device. Working closely with scientists and entrepreneurs who grew their companies into thriving businesses, we have worked alongside to support their endeavors from whiteboard to clinical trial and beyond.
Industry Highlights
Celebrating our founders’successes
2013
NanoString Files IPO Worth $54 Million
Molecular Diagnostics
2020
Lumos Pharma Sets Sights on SPAC
Drug Discovery
2020
Oric Pharmaceuticals IPO Raises $120 Million
Drug Discovery
2020
Applied Molecular Transport Closes IPO at $154 Million
Pharmaceuticals
2020
ALX Oncology Prices IPO at $161 Million
Immuno-Oncology
2020
HintMD is Acquired by Revance Therapeutics
Mobile Healthcare Platform
2020
Athira Pharma Closes $204 Million IPO
Drug Discovery
2020
PMV Pharmaceuticals Joins Nasdaq with $211 Million IPO
Drug Discovery
2020
Artelo Biosciences Announces $6.6 Million Public Offering
We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content. For more information or to opt-out, visit our privacy policy.